Gomekli (mirdametinib)

**Product type:** Human Prescription Drug

**Active ingredient:** MIRDAMETINIB

**Strength:** 1 mg/1

**Dosage form:** Tablet, For Suspension

**Route:** Oral

**Labeler:** SpringWorks Therapeutics, Inc.

**Marketing category:** NDA (NDA219379)

**Pharmacologic class:** Kinase Inhibitor [EPC], Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA], Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]